Difference between revisions of "DZI20-239-Case-2"

From MGH Learn Pathology
(Edited automatically from page DZI20-239.)
(Automatic edit to upgrade to new templates)
Line 1: Line 1:
−
{{dziCase
+
{{ServiceRequestCase
−
|qc=yes
+
|identifier=DZI20-239-Case-2
−
|qcuser=Aja51
+
|intent=order
−
|qctime=Nov 30, 2020 14:14:58
+
|category=409073007
−
|order_date=November 25, 2020 10:19:55 PM
+
|priority=routine
−
|user=Vn048
+
|orderDetail=case
−
|dziorder=DZI20-239
+
|locationCode=learn
−
|case_id=2
+
|basedOn=DZI20-239
−
|publish_timestamp=12/02/2020 13:00:00
+
|code=outs
−
|clinical_hx=68 yo man presenting to the ED with acute chest pain c/f aortic dissection noted to have an abnormal CBC and smear
+
|supportingInfo=One year reported history of ET never confirmed by bone marrow review on hydroxyurea.
 +
The current findings are suggestive of either progression of the disease or question the original diagnosis. If this was the diagnostic specimen MDS/MPN overlap would be a consideration.
 +
|reasonCode=68 yo man presenting to the ED with acute chest pain c/f aortic dissection noted to have an abnormal CBC and smear
 
WBC 21.02*; HGB 7.3*; HCT 22.7*; PLT 138*; MCV 96.
 
WBC 21.02*; HGB 7.3*; HCT 22.7*; PLT 138*; MCV 96.
 
DIFF: Neutr 64; Lymph 12; Monos 1; Basos 1; Bands 1; Metas 2; Myelos 16; Other WBCs 3.
 
DIFF: Neutr 64; Lymph 12; Monos 1; Basos 1; Bands 1; Metas 2; Myelos 16; Other WBCs 3.
−
|case_diagnosis=One year reported history of ET never confirmed by bone marrow review on hydroxyurea.
+
|subject=public
−
The current findings are suggestive of either progression of the disease or question the original diagnosis. If this was the diagnostic specimen MDS/MPN overlap would be a consideration.
+
|performer=Vn048
 +
|authoredOn=November 25, 2020 10:19:55 PM
 +
|requester=Vn048
 +
|sequence=2
 
}}
 
}}
−
{{dziSlide
+
{{Media
−
|order_date=November 25, 2020 10:19:55 PM
+
|basedOn=DZI20-239-Case-2
−
|user=Vn048
+
|type=image
−
|source_filename=Z0FBQUFBQmZ2dHFoczQ3cVJJOFMyZVpsaEk4ZUJVcUhxOG1xeldUOUhBQ3V0bllIWnVlR1Uzak5HNUk2N19oWGxNUFVjNFNzLUd1SkJNSFpwNWpwR1BWQjU1T19OY0trenc9PQ
+
|view=show
−
|slide_anatomy=Show
+
|partOf=DZI20-239
 +
|frames=1
 +
|identifier=DZI20-239-Case-2_1
 +
|createdDateTime=November 25, 2020 10:19:55 PM
 +
|operator=Vn048
 +
|subject=Z0FBQUFBQmZ2dHFoczQ3cVJJOFMyZVpsaEk4ZUJVcUhxOG1xeldUOUhBQ3V0bllIWnVlR1Uzak5HNUk2N19oWGxNUFVjNFNzLUd1SkJNSFpwNWpwR1BWQjU1T19OY0trenc9PQ
 +
|modality=mrxs
 
}}
 
}}

Revision as of 11:59, March 9, 2022

DZI20-239-Case-2
68 yo man presenting to the ED with acute chest pain c/f aortic dissection noted to have an abnormal CBC and smear

WBC 21.02*; HGB 7.3*; HCT 22.7*; PLT 138*; MCV 96.

DIFF: Neutr 64; Lymph 12; Monos 1; Basos 1; Bands 1; Metas 2; Myelos 16; Other WBCs 3.
One year reported history of ET never confirmed by bone marrow review on hydroxyurea. The current findings are suggestive of either progression of the disease or question the original diagnosis. If this was the diagnostic specimen MDS/MPN overlap would be a consideration.
December 2, 2020





Retrieved from "https://learn.mghpathology.org/index.php?title=DZI20-239-Case-2&oldid=80046"
  • Powered by MediaWiki
  • Search Powered by Cargo
  • Massachusetts General Hospital